- Home
- DVA vs GTLS Comparison
DVA vs GTLS Comparison
Compare DVA & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- GTLS
- Stock Information
- Founded
- DVA 1994
- GTLS 1859
- Country
- DVA United States
- GTLS United States
- Employees
- DVA N/A
- GTLS N/A
- Industry
- DVA Misc Health and Biotechnology Services
- GTLS Metal Fabrications
- Sector
- DVA Health Care
- GTLS Industrials
- Exchange
- DVA Nasdaq
- GTLS Nasdaq
- Market Cap
- DVA 10.9B
- GTLS 9.2B
- IPO Year
- DVA 1995
- GTLS 1992
- Fundamental
- Price
- DVA $142.56
- GTLS $168.38
- Analyst Decision
- DVA Hold
- GTLS Strong Buy
- Analyst Count
- DVA 4
- GTLS 10
- Target Price
- DVA $157.00
- GTLS $198.80
- AVG Volume (30 Days)
- DVA 857.4K
- GTLS 1.2M
- Earning Date
- DVA 08-05-2025
- GTLS 07-31-2025
- Dividend Yield
- DVA N/A
- GTLS N/A
- EPS Growth
- DVA 14.90
- GTLS 416.59
- EPS
- DVA 10.11
- GTLS 4.96
- Revenue
- DVA $12,968,524,000.00
- GTLS $4,211,100,000.00
- Revenue This Year
- DVA $6.46
- GTLS $13.53
- Revenue Next Year
- DVA $3.24
- GTLS $9.61
- P/E Ratio
- DVA $14.10
- GTLS $34.52
- Revenue Growth
- DVA 5.11
- GTLS 11.65
- 52 Week Low
- DVA $131.76
- GTLS $101.60
- 52 Week High
- DVA $179.60
- GTLS $220.03
- Technical
- Relative Strength Index (RSI)
- DVA 55.72
- GTLS 67.25
- Support Level
- DVA $135.07
- GTLS $160.41
- Resistance Level
- DVA $147.45
- GTLS $169.81
- Average True Range (ATR)
- DVA 3.05
- GTLS 4.93
- MACD
- DVA 0.82
- GTLS 2.82
- Stochastic Oscillator
- DVA 61.83
- GTLS 100.00
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company.